NCT05712681

Clinical Trial to Evaluate Food-Effects on Pharmacokinetics and Pharmacodynamics of Oral Single Dose of JP-1366 Tablet in Healthy Volunteers

A Randomized, Open-label, Crossover Phase 1 Clinical Trial to Evaluate Food-Effects on Pharmacokinetics and Pharmacodynamics of Oral Single Dose of JP-1366 Tablet in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Onconic Therapeutics Inc. · Industry
• Sex: All
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

To Evaluate Food-Effects on Pharmacokinetics and Pharmacodynamics of Oral single dose of JP-1366 tablet in Healthy volunteers

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	JP-1366 20mg tablet	T : JP-1366 20mg tablet after the meal
DRUG	JP-1366 20mg tablet	R : JP-1366 20mg tablet under fasting condition

Timeline

• Start date: 2023-03-29
• Primary completion: 2023-05-04
• Completion: 2023-05-18
• First posted: 2023-02-03
• Last updated: 2024-08-26

Locations

1 site across 1 country: South Korea